First Time Loading...
H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 210 000 KRW -0.71% Market Closed
Updated: May 2, 2024

Intrinsic Value

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. [ Read More ]

The intrinsic value of one Hugel Inc stock under the Base Case scenario is 203 579.1 KRW. Compared to the current market price of 210 000 KRW, Hugel Inc is Overvalued by 3%.

Key Points:
Intrinsic Value
Base Case
203 579.1 KRW
Overvaluation 3%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hugel Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Hugel Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Hugel Inc

Provide an overview of the primary business activities
of Hugel Inc.

What unique competitive advantages
does Hugel Inc hold over its rivals?

What risks and challenges
does Hugel Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hugel Inc.

Provide P/S
for Hugel Inc.

Provide P/E
for Hugel Inc.

Provide P/OCF
for Hugel Inc.

Provide P/FCFE
for Hugel Inc.

Provide P/B
for Hugel Inc.

Provide EV/S
for Hugel Inc.

Provide EV/GP
for Hugel Inc.

Provide EV/EBITDA
for Hugel Inc.

Provide EV/EBIT
for Hugel Inc.

Provide EV/OCF
for Hugel Inc.

Provide EV/FCFF
for Hugel Inc.

Provide EV/IC
for Hugel Inc.

Show me price targets
for Hugel Inc made by professional analysts.

What are the Revenue projections
for Hugel Inc?

How accurate were the past Revenue estimates
for Hugel Inc?

What are the Net Income projections
for Hugel Inc?

How accurate were the past Net Income estimates
for Hugel Inc?

What are the EPS projections
for Hugel Inc?

How accurate were the past EPS estimates
for Hugel Inc?

What are the EBIT projections
for Hugel Inc?

How accurate were the past EBIT estimates
for Hugel Inc?

Compare the revenue forecasts
for Hugel Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hugel Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hugel Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hugel Inc compared to its peers.

Compare the P/E ratios
of Hugel Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Hugel Inc with its peers.

Analyze the financial leverage
of Hugel Inc compared to its main competitors.

Show all profitability ratios
for Hugel Inc.

Provide ROE
for Hugel Inc.

Provide ROA
for Hugel Inc.

Provide ROIC
for Hugel Inc.

Provide ROCE
for Hugel Inc.

Provide Gross Margin
for Hugel Inc.

Provide Operating Margin
for Hugel Inc.

Provide Net Margin
for Hugel Inc.

Provide FCF Margin
for Hugel Inc.

Show all solvency ratios
for Hugel Inc.

Provide D/E Ratio
for Hugel Inc.

Provide D/A Ratio
for Hugel Inc.

Provide Interest Coverage Ratio
for Hugel Inc.

Provide Altman Z-Score Ratio
for Hugel Inc.

Provide Quick Ratio
for Hugel Inc.

Provide Current Ratio
for Hugel Inc.

Provide Cash Ratio
for Hugel Inc.

What is the historical Revenue growth
over the last 5 years for Hugel Inc?

What is the historical Net Income growth
over the last 5 years for Hugel Inc?

What is the current Free Cash Flow
of Hugel Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hugel Inc.

Financials

Balance Sheet Decomposition
Hugel Inc

Current Assets 567.8B
Cash & Short-Term Investments 479.2B
Receivables 49.1B
Other Current Assets 39.5B
Non-Current Assets 361.5B
Long-Term Investments 21B
PP&E 134.7B
Intangibles 182.3B
Other Non-Current Assets 23.4B
Current Liabilities 57.4B
Accounts Payable 2.9B
Accrued Liabilities 4.6B
Other Current Liabilities 49.8B
Non-Current Liabilities 124.5B
Long-Term Debt 89.9B
Other Non-Current Liabilities 34.6B
Efficiency

Earnings Waterfall
Hugel Inc

Revenue
319.7B KRW
Cost of Revenue
-73.5B KRW
Gross Profit
246.2B KRW
Operating Expenses
-128.4B KRW
Operating Income
117.8B KRW
Other Expenses
-24.7B KRW
Net Income
93.1B KRW

Free Cash Flow Analysis
Hugel Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hugel Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROIC
65/100
Profitability
Score

Hugel Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hugel Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Hugel Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hugel Inc

Wall Street analysts forecast Hugel Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hugel Inc is 225 547.5 KRW with a low forecast of 181 800 KRW and a high forecast of 262 500 KRW.

Lowest
Price Target
181 800 KRW
13% Downside
Average
Price Target
225 547.5 KRW
7% Upside
Highest
Price Target
262 500 KRW
25% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Hugel Inc

1M 1M
+8%
6M 6M
+49%
1Y 1Y
+88%
3Y 3Y
+16%
5Y 5Y
+50%
10Y 10Y
+274%
Annual Price Range
210 000
52w Low
100 800
52w High
221 000
Price Metrics
Average Annual Return 1.86%
Standard Deviation of Annual Returns 30.24%
Max Drawdown -62%
Shares Statistics
Market Capitalization 2.3T KRW
Shares Outstanding 11 258 200
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Hugel Inc

Country

Korea

Industry

Biotechnology

Market Cap

2.3T KRW

Dividend Yield

0%

Description

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2015-12-24. The firm's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The firm sells its products in domestic and overseas markets.

Contact

GANGWON-DO
Chuncheon
61-20, Sinbuk-ro, Sinbuk-eup
+82338155200
http://www.hugel.co.kr/

IPO

2015-12-24

Employees

-

Officers

CEO & Executive Director
Mr. Ji-hoon Sohn
MD & CFO
J. T. Kim
VP and Chief Sales & Marketing Officer
Seonho Han
VP & Chief Production Officer
Mr. Soon-Woo Kwon
MD & Chief Strategy Officer
Jennifer Rho
MD & Head of Marketing
Minjong Kang
Show More
MD & Head of Cosmetics
Jihye Song
MD & Chief Production Officer
Young Mahn Yoo
Show Less

See Also

Discover More
What is the Intrinsic Value of one Hugel Inc stock?

The intrinsic value of one Hugel Inc stock under the Base Case scenario is 203 579.1 KRW.

Is Hugel Inc stock undervalued or overvalued?

Compared to the current market price of 210 000 KRW, Hugel Inc is Overvalued by 3%.